Definitions

from Wiktionary, Creative Commons Attribution/Share-Alike License.

  • noun A fusion protein, similar to abatacept, used to improve graft survival after transplantation.

Etymologies

Sorry, no etymologies found.

Support

Help support Wordnik (and make this page ad-free) by adopting the word belatacept.

Examples

  • Nulojix, also known by the chemical name belatacept, is an alternative to some older immune suppressants, which cause headaches and nausea and, occasionally, kidney toxicity.

    FDA approves Bristol-Myers new transplant drug 2011

  • Nulojix, also known by the chemical name belatacept, is an alternative to some older immune suppressants, which cause headaches and nausea and, occasionally, kidney toxicity.

    FDA approves Bristol-Myers new transplant drug 2011

  • Bristol expects a Food and Drug Administration decision next week on one of the drugs, belatacept, which is designed to prevent organ rejection in patients receiving kidney transplants.

    Bristol-Myers Resolves Problems at Puerto Rico Plant Peter Loftus 2011

  • Bristol expects a Food and Drug Administration decision next week on one of the drugs, belatacept, which is designed to prevent organ rejection in patients receiving kidney transplants.

    Bristol-Myers Resolves Problems at Puerto Rico Plant Peter Loftus 2011

  • Next up for transplant drugs is Bristol-Myers Squibb's (NYSE: BMY) belatacept, which is awaiting

    The Money Times Brian Orelli 2010

  • Food and Drug Administration (FDA) has accepted, for filing and review, the company's submission of a biologic license application for belatacept, which is in ongoing phase III development for use in kidney transplantation.

    Health News from Medical News Today 2009

  • He estimates belatacept, which Bristol proposes to sell under the brand Nulojix, could generate $600 million in annual sales in 2017.

    Bristol-Myers Resolves Problems at Puerto Rico Plant Peter Loftus 2011

  • Bristol spokeswoman Jennifer Mauer said Thursday the FDA is expected to make a decision by June 15 on belatacept and by Aug. 4 for the new Orencia formulation.

    Bristol-Myers Resolves Problems at Puerto Rico Plant Peter Loftus 2011

  • The New York-based company said it was required to resolve the issues before the FDA would consider approving belatacept and a version of rheumatoid arthritis drug Orencia, which can be injected.

    Bristol-Myers Resolves Problems at Puerto Rico Plant Peter Loftus 2011

  • However, Bristol may be on the verge of introducing several new drugs that could alleviate the pressures, including skin-cancer treatment ipilimumab, diabetes drug dapagliflozin and organ-transplant drug belatacept.

    Bristol-Myers Profit Falls on Prior-Year Asset Gain Peter Loftus 2011

Comments

Log in or sign up to get involved in the conversation. It's quick and easy.